Role of interleukin-6 transsignaling in multiple myeloma and therapeutic implications

被引：0
|
作者：
Burger, R. [1 ]
Broeker, K. [1 ]
Kretschmar, F. [1 ]
Richter, K. [1 ]
Ahrens, T. [1 ]
Wijdenes, J. [2 ]
Rose-John, S. [3 ]
Scheller, J. [3 ]
Guenther, A. [1 ]
Gramatzki, M. [1 ]
机构：
[1] Univ Kiel, Div Stem Cell Transplantat & Immunotherapy, Dept Med 2, Kiel, Germany
[2] Gen Probe Diaclone, Besancon, France
[3] Univ Kiel, Dept Biochem, Kiel, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [21] INTERLEUKIN-6, A NEW TARGET FOR THERAPY IN MULTIPLE-MYELOMA
    VANOERS, MHJ
    VANZAANEN, HCT
    LOKHORST, HM
    ANNALS OF HEMATOLOGY, 1993, 66 (05) : 219 - 223
  • [22] Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma
    Pulkki, K
    Pelliniemi, TT
    Rajamaki, A
    Tienhaara, A
    Laakso, M
    Lahtinen, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (02) : 370 - 374
  • [23] Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications
    Smetana, Karel, Jr.
    Brabek, Jan
    IN VIVO, 2020, 34 : 1589 - 1592
  • [24] DIFFERENTIAL REGULATION OF INTERLEUKIN-6 RECEPTORS BY INTERLEUKIN-6 AND INTERFERONS IN MULTIPLE-MYELOMA CELL-LINES
    LASFAR, A
    WIETZERBIN, J
    BILLARD, C
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (01) : 124 - 130
  • [25] Interleukin-6 and interleukin-4 levels in multiple myeloma and correlation of interleukin-6 with beta 2 microglobulin and serum creatinine
    Singh, Usha
    Shevra, Chhaya Rani
    Singh, Shailja
    Singh, Niladri
    Kumar, Sandip
    Rai, Madhukar
    CLINICAL CANCER INVESTIGATION JOURNAL, 2015, 4 (02): : 211 - 215
  • [26] Role of interleukin-6 in cancer progression and therapeutic resistance
    Kumari, Neeraj
    Dwarakanath, B. S.
    Das, Asmita
    Bhatt, Anant Narayan
    TUMOR BIOLOGY, 2016, 37 (09) : 11553 - 11572
  • [27] EXPRESSION OF INTERLEUKIN-6 AND INTERLEUKIN-6 RECEPTORS IN PEDIATRIC ACUTE LYMPHOBLASTIC-LEUKEMIA - PATHOPHYSIOLOGIC AND THERAPEUTIC IMPLICATIONS
    ZHOU, M
    MA, L
    RIZACK, T
    YEAGER, AM
    FINDLEY, HW
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 729 - 729
  • [28] Optimizing interleukin-6 (IL-6) targeting in multiple myeloma (MM)
    Rossi, J. F.
    Lu, Z. Y.
    Baudard, M.
    Klein, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 154 - 154
  • [29] Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines
    Gaillard, JP
    Liautard, J
    Klein, B
    Brochier, J
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) : 3332 - 3340
  • [30] Evaluation of soluble interleukin-6 receptor serum levels in multiple myeloma
    Scudla, V
    Kubalova, D
    Bacovsky, J
    Lukes, J
    Vavrdova, V
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 501 - 501
12345